COVID-19 Impact on Global Antidiabetics Drug, Market Insights and Forecast to 2026

COVID-19 Impact on Global Antidiabetics Drug, Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Antidiabetics Drug Product Introduction
1.2 Market Segments
1.3 Key Antidiabetics Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Antidiabetics Drug Market Size Growth Rate by Type
1.4.2 Metformin (Biguanides)
1.4.3 Insulin Sensitization Agent (TZD Use)
1.4.4 Sulfonated Ideal Urea Class
1.4.5 Meglitinides
1.4.6 Alpha Glucosidase Inhibitors
1.5 Market by Application
1.5.1 Global Antidiabetics Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Household
1.6 Coronavirus Disease 2019 (Covid-19): Antidiabetics Drug Industry Impact
1.6.1 How the Covid-19 is Affecting the Antidiabetics Drug Industry
1.6.1.1 Antidiabetics Drug Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Antidiabetics Drug Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Antidiabetics Drug Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Antidiabetics Drug Market Size Estimates and Forecasts
2.1.1 Global Antidiabetics Drug Revenue 2015-2026
2.1.2 Global Antidiabetics Drug Sales 2015-2026
2.2 Antidiabetics Drug Market Size by Region: 2020 Versus 2026
2.2.1 Global Antidiabetics Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Antidiabetics Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Antidiabetics Drug Competitor Landscape by Players
3.1 Antidiabetics Drug Sales by Manufacturers
3.1.1 Antidiabetics Drug Sales by Manufacturers (2015-2020)
3.1.2 Antidiabetics Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Antidiabetics Drug Revenue by Manufacturers
3.2.1 Antidiabetics Drug Revenue by Manufacturers (2015-2020)
3.2.2 Antidiabetics Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Antidiabetics Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Antidiabetics Drug Revenue in 2019
3.2.5 Global Antidiabetics Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Antidiabetics Drug Price by Manufacturers
3.4 Antidiabetics Drug Manufacturing Base Distribution, Product Types
3.4.1 Antidiabetics Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antidiabetics Drug Product Type
3.4.3 Date of International Manufacturers Enter into Antidiabetics Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Antidiabetics Drug Market Size by Type (2015-2020)
4.1.1 Global Antidiabetics Drug Sales by Type (2015-2020)
4.1.2 Global Antidiabetics Drug Revenue by Type (2015-2020)
4.1.3 Antidiabetics Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Antidiabetics Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Antidiabetics Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Antidiabetics Drug Revenue Forecast by Type (2021-2026)
4.2.3 Antidiabetics Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Antidiabetics Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Antidiabetics Drug Market Size by Application (2015-2020)
5.1.1 Global Antidiabetics Drug Sales by Application (2015-2020)
5.1.2 Global Antidiabetics Drug Revenue by Application (2015-2020)
5.1.3 Antidiabetics Drug Price by Application (2015-2020)
5.2 Antidiabetics Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Antidiabetics Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Antidiabetics Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Antidiabetics Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Antidiabetics Drug by Country
6.1.1 North America Antidiabetics Drug Sales by Country
6.1.2 North America Antidiabetics Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Antidiabetics Drug Market Facts & Figures by Type
6.3 North America Antidiabetics Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Antidiabetics Drug by Country
7.1.1 Europe Antidiabetics Drug Sales by Country
7.1.2 Europe Antidiabetics Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antidiabetics Drug Market Facts & Figures by Type
7.3 Europe Antidiabetics Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Antidiabetics Drug by Region
8.1.1 Asia Pacific Antidiabetics Drug Sales by Region
8.1.2 Asia Pacific Antidiabetics Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Antidiabetics Drug Market Facts & Figures by Type
8.3 Asia Pacific Antidiabetics Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Antidiabetics Drug by Country
9.1.1 Latin America Antidiabetics Drug Sales by Country
9.1.2 Latin America Antidiabetics Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Antidiabetics Drug Market Facts & Figures by Type
9.3 Central & South America Antidiabetics Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Antidiabetics Drug by Country
10.1.1 Middle East and Africa Antidiabetics Drug Sales by Country
10.1.2 Middle East and Africa Antidiabetics Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Antidiabetics Drug Market Facts & Figures by Type
10.3 Middle East and Africa Antidiabetics Drug Market Facts & Figures by Application
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description, Business Overview and Total Revenue
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Antidiabetics Drug Products Offered
11.1.5 AstraZeneca Recent Development
11.2 Bayer
11.2.1 Bayer Corporation Information
11.2.2 Bayer Description, Business Overview and Total Revenue
11.2.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bayer Antidiabetics Drug Products Offered
11.2.5 Bayer Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Corporation Information
11.3.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
11.3.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Boehringer Ingelheim Antidiabetics Drug Products Offered
11.3.5 Boehringer Ingelheim Recent Development
11.4 Eli-Lilly
11.4.1 Eli-Lilly Corporation Information
11.4.2 Eli-Lilly Description, Business Overview and Total Revenue
11.4.3 Eli-Lilly Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Eli-Lilly Antidiabetics Drug Products Offered
11.4.5 Eli-Lilly Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Corporation Information
11.5.2 Johnson & Johnson Description, Business Overview and Total Revenue
11.5.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Johnson & Johnson Antidiabetics Drug Products Offered
11.5.5 Johnson & Johnson Recent Development
11.6 Merck
11.6.1 Merck Corporation Information
11.6.2 Merck Description, Business Overview and Total Revenue
11.6.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Merck Antidiabetics Drug Products Offered
11.6.5 Merck Recent Development
11.7 Novartis
11.7.1 Novartis Corporation Information
11.7.2 Novartis Description, Business Overview and Total Revenue
11.7.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Novartis Antidiabetics Drug Products Offered
11.7.5 Novartis Recent Development
11.8 Novo Nordisk
11.8.1 Novo Nordisk Corporation Information
11.8.2 Novo Nordisk Description, Business Overview and Total Revenue
11.8.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Novo Nordisk Antidiabetics Drug Products Offered
11.8.5 Novo Nordisk Recent Development
11.9 Sanofi
11.9.1 Sanofi Corporation Information
11.9.2 Sanofi Description, Business Overview and Total Revenue
11.9.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Sanofi Antidiabetics Drug Products Offered
11.9.5 Sanofi Recent Development
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description, Business Overview and Total Revenue
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Antidiabetics Drug Products Offered
11.1.5 AstraZeneca Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Antidiabetics Drug Market Estimates and Projections by Region
12.1.1 Global Antidiabetics Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Antidiabetics Drug Revenue Forecast by Regions 2021-2026
12.2 North America Antidiabetics Drug Market Size Forecast (2021-2026)
12.2.1 North America: Antidiabetics Drug Sales Forecast (2021-2026)
12.2.2 North America: Antidiabetics Drug Revenue Forecast (2021-2026)
12.2.3 North America: Antidiabetics Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Antidiabetics Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Antidiabetics Drug Sales Forecast (2021-2026)
12.3.2 Europe: Antidiabetics Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Antidiabetics Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Antidiabetics Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Antidiabetics Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Antidiabetics Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Antidiabetics Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Antidiabetics Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Antidiabetics Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Antidiabetics Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Antidiabetics Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Antidiabetics Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Antidiabetics Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Antidiabetics Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Antidiabetics Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Antidiabetics Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antidiabetics Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Antidiabetics Drug Market Segments
Table 2. Ranking of Global Top Antidiabetics Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Antidiabetics Drug Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Metformin (Biguanides)
Table 5. Major Manufacturers of Insulin Sensitization Agent (TZD Use)
Table 6. Major Manufacturers of Sulfonated Ideal Urea Class
Table 7. Major Manufacturers of Meglitinides
Table 8. Major Manufacturers of Alpha Glucosidase Inhibitors
Table 9. COVID-19 Impact Global Market: (Four Antidiabetics Drug Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Antidiabetics Drug Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Antidiabetics Drug Players to Combat Covid-19 Impact
Table 14. Global Antidiabetics Drug Market Size Growth Rate by Application 2020-2026 (K Units)
Table 15. Global Antidiabetics Drug Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 16. Global Antidiabetics Drug Sales by Regions 2015-2020 (K Units)
Table 17. Global Antidiabetics Drug Sales Market Share by Regions (2015-2020)
Table 18. Global Antidiabetics Drug Revenue by Regions 2015-2020 (US$ Million)
Table 19. Global Antidiabetics Drug Sales by Manufacturers (2015-2020) (K Units)
Table 20. Global Antidiabetics Drug Sales Share by Manufacturers (2015-2020)
Table 21. Global Antidiabetics Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 22. Global Antidiabetics Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antidiabetics Drug as of 2019)
Table 23. Antidiabetics Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 24. Antidiabetics Drug Revenue Share by Manufacturers (2015-2020)
Table 25. Key Manufacturers Antidiabetics Drug Price (2015-2020) (USD/Unit)
Table 26. Antidiabetics Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Antidiabetics Drug Product Type
Table 28. Date of International Manufacturers Enter into Antidiabetics Drug Market
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. Global Antidiabetics Drug Sales by Type (2015-2020) (K Units)
Table 31. Global Antidiabetics Drug Sales Share by Type (2015-2020)
Table 32. Global Antidiabetics Drug Revenue by Type (2015-2020) (US$ Million)
Table 33. Global Antidiabetics Drug Revenue Share by Type (2015-2020)
Table 34. Antidiabetics Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 35. Global Antidiabetics Drug Sales by Application (2015-2020) (K Units)
Table 36. Global Antidiabetics Drug Sales Share by Application (2015-2020)
Table 37. North America Antidiabetics Drug Sales by Country (2015-2020) (K Units)
Table 38. North America Antidiabetics Drug Sales Market Share by Country (2015-2020)
Table 39. North America Antidiabetics Drug Revenue by Country (2015-2020) (US$ Million)
Table 40. North America Antidiabetics Drug Revenue Market Share by Country (2015-2020)
Table 41. North America Antidiabetics Drug Sales by Type (2015-2020) (K Units)
Table 42. North America Antidiabetics Drug Sales Market Share by Type (2015-2020)
Table 43. North America Antidiabetics Drug Sales by Application (2015-2020) (K Units)
Table 44. North America Antidiabetics Drug Sales Market Share by Application (2015-2020)
Table 45. Europe Antidiabetics Drug Sales by Country (2015-2020) (K Units)
Table 46. Europe Antidiabetics Drug Sales Market Share by Country (2015-2020)
Table 47. Europe Antidiabetics Drug Revenue by Country (2015-2020) (US$ Million)
Table 48. Europe Antidiabetics Drug Revenue Market Share by Country (2015-2020)
Table 49. Europe Antidiabetics Drug Sales by Type (2015-2020) (K Units)
Table 50. Europe Antidiabetics Drug Sales Market Share by Type (2015-2020)
Table 51. Europe Antidiabetics Drug Sales by Application (2015-2020) (K Units)
Table 52. Europe Antidiabetics Drug Sales Market Share by Application (2015-2020)
Table 53. Asia Pacific Antidiabetics Drug Sales by Region (2015-2020) (K Units)
Table 54. Asia Pacific Antidiabetics Drug Sales Market Share by Region (2015-2020)
Table 55. Asia Pacific Antidiabetics Drug Revenue by Region (2015-2020) (US$ Million)
Table 56. Asia Pacific Antidiabetics Drug Revenue Market Share by Region (2015-2020)
Table 57. Asia Pacific Antidiabetics Drug Sales by Type (2015-2020) (K Units)
Table 58. Asia Pacific Antidiabetics Drug Sales Market Share by Type (2015-2020)
Table 59. Asia Pacific Antidiabetics Drug Sales by Application (2015-2020) (K Units)
Table 60. Asia Pacific Antidiabetics Drug Sales Market Share by Application (2015-2020)
Table 61. Latin America Antidiabetics Drug Sales by Country (2015-2020) (K Units)
Table 62. Latin America Antidiabetics Drug Sales Market Share by Country (2015-2020)
Table 63. Latin Americaa Antidiabetics Drug Revenue by Country (2015-2020) (US$ Million)
Table 64. Latin America Antidiabetics Drug Revenue Market Share by Country (2015-2020)
Table 65. Latin America Antidiabetics Drug Sales by Type (2015-2020) (K Units)
Table 66. Latin America Antidiabetics Drug Sales Market Share by Type (2015-2020)
Table 67. Latin America Antidiabetics Drug Sales by Application (2015-2020) (K Units)
Table 68. Latin America Antidiabetics Drug Sales Market Share by Application (2015-2020)
Table 69. Middle East and Africa Antidiabetics Drug Sales by Country (2015-2020) (K Units)
Table 70. Middle East and Africa Antidiabetics Drug Sales Market Share by Country (2015-2020)
Table 71. Middle East and Africa Antidiabetics Drug Revenue by Country (2015-2020) (US$ Million)
Table 72. Middle East and Africa Antidiabetics Drug Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Antidiabetics Drug Sales by Type (2015-2020) (K Units)
Table 74. Middle East and Africa Antidiabetics Drug Sales Market Share by Type (2015-2020)
Table 75. Middle East and Africa Antidiabetics Drug Sales by Application (2015-2020) (K Units)
Table 76. Middle East and Africa Antidiabetics Drug Sales Market Share by Application (2015-2020)
Table 77. AstraZeneca Corporation Information
Table 78. AstraZeneca Description and Major Businesses
Table 79. AstraZeneca Antidiabetics Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 80. AstraZeneca Product
Table 81. AstraZeneca Recent Development
Table 82. Bayer Corporation Information
Table 83. Bayer Description and Major Businesses
Table 84. Bayer Antidiabetics Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 85. Bayer Product
Table 86. Bayer Recent Development
Table 87. Boehringer Ingelheim Corporation Information
Table 88. Boehringer Ingelheim Description and Major Businesses
Table 89. Boehringer Ingelheim Antidiabetics Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 90. Boehringer Ingelheim Product
Table 91. Boehringer Ingelheim Recent Development
Table 92. Eli-Lilly Corporation Information
Table 93. Eli-Lilly Description and Major Businesses
Table 94. Eli-Lilly Antidiabetics Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 95. Eli-Lilly Product
Table 96. Eli-Lilly Recent Development
Table 97. Johnson & Johnson Corporation Information
Table 98. Johnson & Johnson Description and Major Businesses
Table 99. Johnson & Johnson Antidiabetics Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 100. Johnson & Johnson Product
Table 101. Johnson & Johnson Recent Development
Table 102. Merck Corporation Information
Table 103. Merck Description and Major Businesses
Table 104. Merck Antidiabetics Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 105. Merck Product
Table 106. Merck Recent Development
Table 107. Novartis Corporation Information
Table 108. Novartis Description and Major Businesses
Table 109. Novartis Antidiabetics Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 110. Novartis Product
Table 111. Novartis Recent Development
Table 112. Novo Nordisk Corporation Information
Table 113. Novo Nordisk Description and Major Businesses
Table 114. Novo Nordisk Antidiabetics Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 115. Novo Nordisk Product
Table 116. Novo Nordisk Recent Development
Table 117. Sanofi Corporation Information
Table 118. Sanofi Description and Major Businesses
Table 119. Sanofi Antidiabetics Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 120. Sanofi Product
Table 121. Sanofi Recent Development
Table 122. Global Antidiabetics Drug Sales Forecast by Regions (2021-2026) (K Units)
Table 123. Global Antidiabetics Drug Sales Market Share Forecast by Regions (2021-2026)
Table 124. Global Antidiabetics Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 125. Global Antidiabetics Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 126. North America: Antidiabetics Drug Sales Forecast by Country (2021-2026) (K Units)
Table 127. North America: Antidiabetics Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Europe: Antidiabetics Drug Sales Forecast by Country (2021-2026) (K Units)
Table 129. Europe: Antidiabetics Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Asia Pacific: Antidiabetics Drug Sales Forecast by Region (2021-2026) (K Units)
Table 131. Asia Pacific: Antidiabetics Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 132. Latin America: Antidiabetics Drug Sales Forecast by Country (2021-2026) (K Units)
Table 133. Latin America: Antidiabetics Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Middle East and Africa: Antidiabetics Drug Sales Forecast by Country (2021-2026) (K Units)
Table 135. Middle East and Africa: Antidiabetics Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 137. Key Challenges
Table 138. Market Risks
Table 139. Main Points Interviewed from Key Antidiabetics Drug Players
Table 140. Antidiabetics Drug Customers List
Table 141. Antidiabetics Drug Distributors List
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Antidiabetics Drug Product Picture
Figure 2. Global Antidiabetics Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Metformin (Biguanides) Product Picture
Figure 4. Insulin Sensitization Agent (TZD Use) Product Picture
Figure 5. Sulfonated Ideal Urea Class Product Picture
Figure 6. Meglitinides Product Picture
Figure 7. Alpha Glucosidase Inhibitors Product Picture
Figure 8. Global Antidiabetics Drug Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital
Figure 10. Household
Figure 11. Antidiabetics Drug Report Years Considered
Figure 12. Global Antidiabetics Drug Market Size 2015-2026 (US$ Million)
Figure 13. Global Antidiabetics Drug Sales 2015-2026 (K Units)
Figure 14. Global Antidiabetics Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Antidiabetics Drug Sales Market Share by Region (2015-2020)
Figure 16. Global Antidiabetics Drug Sales Market Share by Region in 2019
Figure 17. Global Antidiabetics Drug Revenue Market Share by Region (2015-2020)
Figure 18. Global Antidiabetics Drug Revenue Market Share by Region in 2019
Figure 19. Global Antidiabetics Drug Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Antidiabetics Drug Revenue in 2019
Figure 21. Antidiabetics Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Antidiabetics Drug Sales Market Share by Type (2015-2020)
Figure 23. Global Antidiabetics Drug Sales Market Share by Type in 2019
Figure 24. Global Antidiabetics Drug Revenue Market Share by Type (2015-2020)
Figure 25. Global Antidiabetics Drug Revenue Market Share by Type in 2019
Figure 26. Global Antidiabetics Drug Market Share by Price Range (2015-2020)
Figure 27. Global Antidiabetics Drug Sales Market Share by Application (2015-2020)
Figure 28. Global Antidiabetics Drug Sales Market Share by Application in 2019
Figure 29. Global Antidiabetics Drug Revenue Market Share by Application (2015-2020)
Figure 30. Global Antidiabetics Drug Revenue Market Share by Application in 2019
Figure 31. North America Antidiabetics Drug Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America Antidiabetics Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Antidiabetics Drug Sales Market Share by Country in 2019
Figure 34. North America Antidiabetics Drug Revenue Market Share by Country in 2019
Figure 35. U.S. Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Antidiabetics Drug Market Share by Type in 2019
Figure 40. North America Antidiabetics Drug Market Share by Application in 2019
Figure 41. Europe Antidiabetics Drug Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe Antidiabetics Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Antidiabetics Drug Sales Market Share by Country in 2019
Figure 44. Europe Antidiabetics Drug Revenue Market Share by Country in 2019
Figure 45. Germany Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 48. France Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Antidiabetics Drug Market Share by Type in 2019
Figure 56. Europe Antidiabetics Drug Market Share by Application in 2019
Figure 57. Asia Pacific Antidiabetics Drug Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific Antidiabetics Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Antidiabetics Drug Sales Market Share by Region in 2019
Figure 60. Asia Pacific Antidiabetics Drug Revenue Market Share by Region in 2019
Figure 61. China Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 62. China Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 68. India Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 80. Philippines Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 82. Vietnam Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Antidiabetics Drug Market Share by Type in 2019
Figure 84. Asia Pacific Antidiabetics Drug Market Share by Application in 2019
Figure 85. Latin America Antidiabetics Drug Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Antidiabetics Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Antidiabetics Drug Sales Market Share by Country in 2019
Figure 88. Latin America Antidiabetics Drug Revenue Market Share by Country in 2019
Figure 89. Mexico Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Antidiabetics Drug Market Share by Type in 2019
Figure 96. Latin America Antidiabetics Drug Market Share by Application in 2019
Figure 97. Middle East and Africa Antidiabetics Drug Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa Antidiabetics Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Antidiabetics Drug Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Antidiabetics Drug Revenue Market Share by Country in 2019
Figure 101. Turkey Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Antidiabetics Drug Market Share by Type in 2019
Figure 108. Middle East and Africa Antidiabetics Drug Market Share by Application in 2019
Figure 109. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Eli-Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. North America Antidiabetics Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. North America Antidiabetics Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Europe Antidiabetics Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Europe Antidiabetics Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Asia Pacific Antidiabetics Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 123. Asia Pacific Antidiabetics Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Latin America Antidiabetics Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 125. Latin America Antidiabetics Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Middle East and Africa Antidiabetics Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 127. Middle East and Africa Antidiabetics Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Porter's Five Forces Analysis
Figure 129. Channels of Distribution
Figure 130. Distributors Profiles
Figure 131. Bottom-up and Top-down Approaches for This Report
Figure 132. Data Triangulation
Figure 133. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Metformin Hydrochloride Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Metformin hydrochloride is The raw material of finished product metformin hydrochloride drugs. That is The API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in The management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystall......

Global Antidiabetic Sulphonylureas Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 112

Market Overview of Global Antidiabetic Sulphonylureas market: According to our latest research, the global Antidiabetic Sulphonylureas market looks promising in the next 5 years. As of 2022, the global Antidiabetic Sulphonylureas market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of t......

Global Insulin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101

According to our LPI (LP Information) latest study, the global Insulin market size was valued at US$ million in 2023. With growing demand in downstream market, the Insulin is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Insulin market. Insulin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization......

Global Insulin API Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116

According to our LPI (LP Information) latest study, the global Insulin API market size was valued at US$ 1707.6 million in 2023. With growing demand in downstream market, the Insulin API is forecast to a readjusted size of US$ 2101.4 million by 2030 with a CAGR of 3.0% during review period. The research report highlights the growth potential of the global Insulin API market. Insulin API are expected to show stable growth in the future market. However, product differentiation, reducing co......

Global Glucagon Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101

According to our LPI (LP Information) latest study, the global Glucagon market size was valued at US$ 543.9 million in 2023. With growing demand in downstream market, the Glucagon is forecast to a readjusted size of US$ 835.7 million by 2030 with a CAGR of 6.3% during review period. The research report highlights the growth potential of the global Glucagon market. Glucagon are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......

Global Acarbose Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Acarbose market size was valued at US$ 135.8 million in 2023. With growing demand in downstream market, the Acarbose is forecast to a readjusted size of US$ 165.9 million by 2030 with a CAGR of 2.9% during review period. The research report highlights the growth potential of the global Acarbose market. Acarbose are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......

Global Insulin Glargine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 77

According to our LPI (LP Information) latest study, the global Insulin Glargine market size was valued at US$ 6562.1 million in 2023. With growing demand in downstream market, the Insulin Glargine is forecast to a readjusted size of US$ 8722.5 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Insulin Glargine market. Insulin Glargine are expected to show stable growth in the future market. However, product differen......

Global Liraglutide Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 103

According to our LPI (LP Information) latest study, the global Liraglutide market size was valued at US$ million in 2023. With growing demand in downstream market, the Liraglutide is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Liraglutide market. Liraglutide are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ch......

Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global Glucagon Like Peptide-1 (GLP-1) Agonists market size was valued at US$ 8624.4 million in 2023. With growing demand in downstream market, the Glucagon Like Peptide-1 (GLP-1) Agonists is forecast to a readjusted size of US$ 21310 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Glucagon Like Peptide-1 (GLP-1) Agonists market. Glucagon Like Peptide-1 (GL......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs